Batangjawa, Baby Boy .

HRN: 23-76-78  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2023
AMPICILLIN 500MG (VIAL)
10/31/2023
11/06/2023
IV
165mg
BID
Potentially Septic Newborn
Checking Final Appropriateness 
10/31/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/31/2023
11/06/2023
IV
50mg
OD
Potentially Septic Newborn
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: